The Brigham Board Review in Oncology

Brigham and Women’s Hospital and Oakstone Board Review

Prepare for your medical oncology board exam with this in-depth CME program. Ideal for MOC.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
  • Audio
  • Combo
1395.0000
SKU: 212

Earn CME Credit with this Comprehensive Board Review in Oncology

The Brigham Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will enhance patient care while you prep for the board exam by learning to:

  • Apply recommended Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex Oncologic disorders
  • Identify and apply current therapeutic options for Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to Oncology

Discover New Guidelines

A clinically based update, this learn-at-your-own-pace course in Oncology provides a maximum of 31.25 AMA PRA Category 1 Credits and 31.25 MOC points. Available online or on disk, it provides access to unbiased, evidence-based content and case-based reviews so that you may expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

  • Molecular Genetics of Cancer - Levi A. Garraway, MD, PhD
  • Advances in Cancer Drug Development - Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients - Joel T. Katz, MD
  • Symptom Management in Patients with Cancer - Janet L. Abrahm, MD
  • Communication: The Key to Excellence in End-of-Life Care - Susan D. Block, MD
  • Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes - Benjamin L. Ebert, MD, PhD
  • Acute Leukemias - Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome - David P. Steensma, MD
  • Chronic Myelogenous Leukemia - Joseph H. Antin. MD
  • Myeloproliferative Syndromes - Ann M. Mullally, MD
  • Multiple Myeloma - Kenneth C. Anderson, MD
  • Waldenstrom’s Macroglobulemia, Amyloidosis - Irene M. Ghobrial, MD
  • Low Grade Lymphomas - Caron A. Jacobson, MD
  • High Grade Lymphomas - Arnold S. Freedman, MD
  • Hodgkin's Lymphoma - George P. Canellos, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies - Matthew S. Davids, MD
  • Head and Neck Cancer - Robert I. Haddad, MD
  • Natural History, Screening, Surgery, Small Cell Lung Cancer - Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer - Mark Awad, MD
  • Mesothelioma and Thymoma - Geoffrey R. Oxnard, MD
  • Thyroid Cancer - Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors - Matthew H. Kulke, MD
  • Esophageal and Gastric Cancer - Charles S. Fuchs, MD, MPH
  • Pancreatic and Hepatobilary Cancer - Brian M. Wolpin, MD
  • Anal Cancers - Robert J. Mayer, MD
  • Colorectal Cancers - Robert J. Mayer, MD
  • Gastrointestinal Cancer- Genetic Syndromes - Matthew Yurgelun, MD
  • Germ Cell Tumor - Maximizing Cure While Minimizing the Burden of Therapy - Christopher J. Sweeney, MBBS
  • Renal and Bladder Cancer - Toni K. Choueiri, MD
  • Prostate Cancer Part I: Overview and Management of Localized Disease - Atish Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer - Atish Choudhury, MD, PhD
  • Melanoma - F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) - George D. Demetri, MD
  • Ovarian Cancer - Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer - Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology - David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening and Prevention - Judy E. Garber, MD, MPH
  • Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS - Harold J. Burstein, MD, PhD
  • Management for HER2-Positive and Triple Negative Breast Cancer - Eric P. Winer, MD
  • Breast Cancer Survivorship - Ann H. Partridge, MD, MPH

Course Directors

Edwin P. Alyea, III, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Associate Director, Bone Marrow/Stem Cell Transplantation Program
  • Director, Oncology Hospital Medicine
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Course Director
The Brigham Board Review
Distance Learning Series

Ajay K. Singh, MBBS, FRCP (UK), MBA

  • Senior Associate Dean for Global and Continuing Education
  • Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program
  • Harvard Medical School
  • Director, Office of Postgraduate Medical Education
  • Physician, Division of Nephrology, Department of Medicine
  • Brigham and Women’s Hospital

 

Nancy Berliner, MD

  • Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Chief, Department of Medicine
  • Brigham and Women's Hospital

Faculty

Janet L. Abrahm, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Kenneth C. Anderson, MD

  • Kraft Family Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Joseph H. Antin, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark Awad, MD, PhD

  • Instructor In Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Susan D. Block, MD

  • Professor of Psychiatry
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Psychiatry
  • Brigham and Women’s Hospital

Harold Burstein, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

George P. Canellos, MD

  • William Rosenberg Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Atish Choudhury, MD, PhD

  • Instructor In Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Toni Choueiri, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew S. Davids, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Daniel J. DeAngelo, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

George D. Demetri, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Benjamin L. Ebert, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Arnold S. Freedman, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Charles S. Fuchs, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Judy E. Garber, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Levi A. Garraway, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Irene M. Ghobrial, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert I. Haddad, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

F. Stephen Hodi, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

 

Caron A. Jacobson, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Bruce E. Johnson, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Joel Katz, MD

  • Associate Professor of Medicine
  • Division of Infectious Diseases
  • Department of Medicine
  • Brigham and Women’s Hospital

Panagiotis A. Konstantinopoulos, MD, PhD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew H. Kulke, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jochen Lorch, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ursula A. Matulonis, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert J. Mayer, MD

  • Stephen B. Kay Family Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ann M. Mullally, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Geoffrey R. Oxnard, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ann H. Partridge, MD, MPH

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David A. Reardon, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Geoffrey I. Shapiro, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert J. Soiffer, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David P. Steensma, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Christopher J. Sweeney, MBBS

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Eric P. Winer, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Brian M. Wolpin, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew Yurgelun, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Accreditation

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 31.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 31.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Date of Original Release: June 30, 2016
Termination Date: June 30, 2019

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Apply current/recommended Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex Oncologic disorders
  • Identify and apply current therapeutic options for Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to Oncology
  • Illustrate knowledge of pathophysiology as it applies to management of Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Oncology examinations

Intended Audience

This course is designed to provide Hematologists, Oncologists, Hematology-Oncology fellows/trainees, and Internists with new knowledge and management strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty exam in Hematology or Medical Oncology.

oakstone is a division of ebix

Ebix is a leading international supplier of On-Demand software and E-commerce to the insurance, financial and health care industries. A.D.A.M. is a business unit of Ebix focused on providing innovative multimedia health content trusted by best-in-class websites, consumer health portals, health care, biomedical device, pharmaceutical, and academic organizations.